Cargando…

Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases

BACKGROUND: Colorectal liver metastases attached major intrahepatic vessels has been considered to be a risk factor for survival outcome after liver resection. The present study aimed to clarify the outcomes of R1 surgery (margin < 1 mm) in CRLM patients, distinguishing parenchymal margin R1 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei, Cui, Yong, Wu, Xiao-Gang, Chen, Feng-Lin, Wang, Kun, Sun, Ying-Shi, Xing, Bao-Cai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290376/
https://www.ncbi.nlm.nih.gov/pubmed/37353772
http://dx.doi.org/10.1186/s12893-023-01971-2
_version_ 1785062482887311360
author Liu, Wei
Cui, Yong
Wu, Xiao-Gang
Chen, Feng-Lin
Wang, Kun
Sun, Ying-Shi
Xing, Bao-Cai
author_facet Liu, Wei
Cui, Yong
Wu, Xiao-Gang
Chen, Feng-Lin
Wang, Kun
Sun, Ying-Shi
Xing, Bao-Cai
author_sort Liu, Wei
collection PubMed
description BACKGROUND: Colorectal liver metastases attached major intrahepatic vessels has been considered to be a risk factor for survival outcome after liver resection. The present study aimed to clarify the outcomes of R1 surgery (margin < 1 mm) in CRLM patients, distinguishing parenchymal margin R1 and attached to major intrahepatic vessels R1. METHODS: In present study, 283 CRLM patients who were evaluated to be attached to major intrahepatic vessels initially and underwent liver resection following preoperative chemotherapy. They were assigned to two following groups: R0 (n = 167), R1 parenchymal (n = 58) and R1 vascular (n = 58). The survival outcomes and local recurrence rates were analyzed in each group. RESULTS: Overall, 3- and 5-year overall survival rates after liver resection were 53.0% and 38.2% (median overall survival 37 months). Five-year overall survival was higher in patients with R0 than parenchymal R1 (44.9%% vs. 26.3%, p = 0.009), whereas there was no significant difference from patients with vascular R1 (34.3%, p = 0.752). In the multivariable analysis, preoperative chemotherapy > 4 cycles, clinical risk score 3–5, RAS mutation, parenchymal R1 and CA199 > 100 IU/ml were identified as independent predictive factors of overall survival (p < 0.05). There was no significant difference for local recurrence among three groups. CONCLUSION: Parenchymal R1 resection was independent risk factor for CRLM. Vascular R1 surgery achieved survival outcomes equivalent to R0 resection. Non-anatomic liver resection for CRLM attached to intrahepatic vessels might be pursued to increase patient resectability by preoperative chemotherapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-023-01971-2.
format Online
Article
Text
id pubmed-10290376
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102903762023-06-25 Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases Liu, Wei Cui, Yong Wu, Xiao-Gang Chen, Feng-Lin Wang, Kun Sun, Ying-Shi Xing, Bao-Cai BMC Surg Research BACKGROUND: Colorectal liver metastases attached major intrahepatic vessels has been considered to be a risk factor for survival outcome after liver resection. The present study aimed to clarify the outcomes of R1 surgery (margin < 1 mm) in CRLM patients, distinguishing parenchymal margin R1 and attached to major intrahepatic vessels R1. METHODS: In present study, 283 CRLM patients who were evaluated to be attached to major intrahepatic vessels initially and underwent liver resection following preoperative chemotherapy. They were assigned to two following groups: R0 (n = 167), R1 parenchymal (n = 58) and R1 vascular (n = 58). The survival outcomes and local recurrence rates were analyzed in each group. RESULTS: Overall, 3- and 5-year overall survival rates after liver resection were 53.0% and 38.2% (median overall survival 37 months). Five-year overall survival was higher in patients with R0 than parenchymal R1 (44.9%% vs. 26.3%, p = 0.009), whereas there was no significant difference from patients with vascular R1 (34.3%, p = 0.752). In the multivariable analysis, preoperative chemotherapy > 4 cycles, clinical risk score 3–5, RAS mutation, parenchymal R1 and CA199 > 100 IU/ml were identified as independent predictive factors of overall survival (p < 0.05). There was no significant difference for local recurrence among three groups. CONCLUSION: Parenchymal R1 resection was independent risk factor for CRLM. Vascular R1 surgery achieved survival outcomes equivalent to R0 resection. Non-anatomic liver resection for CRLM attached to intrahepatic vessels might be pursued to increase patient resectability by preoperative chemotherapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-023-01971-2. BioMed Central 2023-06-23 /pmc/articles/PMC10290376/ /pubmed/37353772 http://dx.doi.org/10.1186/s12893-023-01971-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Wei
Cui, Yong
Wu, Xiao-Gang
Chen, Feng-Lin
Wang, Kun
Sun, Ying-Shi
Xing, Bao-Cai
Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases
title Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases
title_full Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases
title_fullStr Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases
title_full_unstemmed Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases
title_short Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases
title_sort tumor attachment to major intrahepatic vascular for colorectal liver metastases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290376/
https://www.ncbi.nlm.nih.gov/pubmed/37353772
http://dx.doi.org/10.1186/s12893-023-01971-2
work_keys_str_mv AT liuwei tumorattachmenttomajorintrahepaticvascularforcolorectallivermetastases
AT cuiyong tumorattachmenttomajorintrahepaticvascularforcolorectallivermetastases
AT wuxiaogang tumorattachmenttomajorintrahepaticvascularforcolorectallivermetastases
AT chenfenglin tumorattachmenttomajorintrahepaticvascularforcolorectallivermetastases
AT wangkun tumorattachmenttomajorintrahepaticvascularforcolorectallivermetastases
AT sunyingshi tumorattachmenttomajorintrahepaticvascularforcolorectallivermetastases
AT xingbaocai tumorattachmenttomajorintrahepaticvascularforcolorectallivermetastases